Immunoradiometric assay of carcinoembryonic antigen with use of avidin-biotin labeling

7Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In evaluating an enzyme-linked immunoassay of carcinoembryonic antigen (CEA) we found that the IgG fraction of polyclonal anti-CEA antibodies (DAKO) bound very well to the walls of polypropylene test tubes. We therefore developed an immunoradiometric CEA assay based on this binding of polyclonal anti-CEA antibody. We biotinylated a commercially available monoclonal antibody (Hybritech) and bound this to the CEA-anti-CEA bound to the tube wall. For detection we used 125I-labeled streptavidin. In comparison with several immunoassays for CEA this system offered several advantages such as greater linearity of the standard curve (from 0 to 74 μg/L), a steeper dose-response curve, and smaller coefficients of variation in the clinically useful range. This assay system may be used for other large molecules, so that only one tracer, the 125I-labeled streptavidin, has to be labeled; thus the technique seems suited for several different assays.

Cite

CITATION STYLE

APA

Peters, J., Schmidt-Gayk, H., Peters, B., Armbruster, F. P., Quentmeier, A., & Mathias, D. (1989). Immunoradiometric assay of carcinoembryonic antigen with use of avidin-biotin labeling. Clinical Chemistry, 35(4), 573–576. https://doi.org/10.1093/clinchem/35.4.573

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free